An improved understanding of the cellular origin and pathogenesis of these pediatric adrenal neoplasms will contribute to a more efficient subtype classification and allow more precise and effective treatment of these young patients; in particular, the HIF-MYC/MAX interaction should be further considered. This evidence concerns the gene MAX and adrenal gland neoplasm.